Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02599714
Title Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer (PASTOR)
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications

estrogen-receptor positive breast cancer

Therapies

Fulvestrant + Palbociclib + Vistusertib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Encinitas California 92024 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Liverpool L7 8XP United Kingdom Details
Research Site London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field